_(1).png){kind=logo}
₹ 14792
₹327- ₹344
43
₹371.15
7.89
19 Oct 2026
Download22 Oct 2026
23 Oct 2026
Application Details
Sahajanand Medical Technologies IPO is a book build issue of ₹475.48 crores. The issue is entirely an offer for sale of 1.38 crore shares of ₹475.48 crore.
Sahajanand Medical Technologies IPO opens for subscription on Oct 15, 2026 and closes on Oct 19, 2026. The allotment for the Sahajanand Medical Technologies IPO is expected to be finalized on Oct 21, 2026. Sahajanand Medical Technologies IPO will list on NSE and BSE with a tentative listing date fixed as Oct 23, 2026.
Sahajanand Medical Technologies IPO is set issue price band at ₹327 to ₹344 per share. The lot size for an application is 43 shares. The minimum amount of investment required by an individual investor (retail) is ₹14,792 (43 shares) (based on upper price).
Motilal Oswal Investment Advisors Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue.
About Sahajanand Medical Technologies Limited
Incorporated in October 2001, Sahajanand Medical Technologies Limited is a medical technology company engaged in the development, manufacturing and marketing of technologically advanced medical devices, primarily focused on vascular intervention and structural heart intervention. Its product portfolio includes coronary stents, coronary balloons, transcatheter aortic valve implantation (TAVI) devices, occluders, renal stents and peripheral drug-coated balloons (DCBs). The Company focuses on research and development, precision manufacturing and clinically supported product innovation. Its flagship brands include Supraflex Cruz, Cocoon and Hydra, serving different areas of interventional cardiology.
The Company operates three manufacturing facilities, two in India and one in Thailand, supported by two R&D centres in India and Thailand. As of June 30, 2026, it had 119 patents granted globally, 78 patent applications in the pipeline and five design registrations in India. Its products were marketed in 77 countries in Fiscal 2026, through direct, hybrid and distributor-led models, with established market presence in India, Europe and other international markets.
The Company reported revenue from operations of ₹12,105.04 million in Fiscal 2026, compared with ₹10,248.79 million in Fiscal 2025 and ₹9,016.04 million in Fiscal 2024.
As of June 30, 2026, it had 1,605 full-time employees, 31 consultants and 707 contract-based employees.
Competitive Strengths
- Extensive global sales and marketing network.
- Strong research and development capabilities.
- Diversified and integrated manufacturing facilities.
- Leadership in India and key international markets.
- Proven M&A and strategic collaboration capabilities.
- Technologically advanced medical devices in high-barrier segments.
- Experienced leadership team backed by reputed institutional investors.
FAQ
IPO stands for "Initial Public Offering." It's the process through which a privately-held company becomes publicly traded by offering its shares to the general public and listing them on a stock exchange for trading. This allows the company to raise capital from investors and grants individuals and institutions the opportunity to invest in and own a portion of the company.
The life cycle of an IPO, or Initial Public Offering, begins with a company's decision to go public. It involves hiring underwriters, registering with regulatory authorities, determining the IPO price, marketing to investors, and the subscription period where investors place orders for shares. After allocation and listing, shares become publicly tradable, and the company enters the secondary market. Ongoing reporting and corporate governance are crucial as the company continues to operate as a publicly-traded entity. The IPO aims to raise capital for growth and provides investors with opportunities to trade shares in the company.
An IPO (Initial Public Offering) is when a private company goes public by selling shares to the public. Investors buy these shares, giving them ownership in the company. It's a way for companies to raise capital and expand. The process involves underwriters, regulatory filings, setting the IPO price, and marketing to investors. After the IPO, shares can be traded on a stock exchange. IPOs offer opportunities and risks, so investors should research and consider carefully.
"Upcoming IPOs" refers to initial public offerings that have been announced by private companies but have not yet occurred. These are companies that plan to go public in the near future by issuing shares to the public and listing them on a stock exchange. Investors often keep an eye on upcoming IPOs as they represent opportunities to invest in companies at their early stages of public trading, potentially capturing growth potential. These offerings are typically accompanied by significant media and investor attention as they approach their launch dates.